Skip to Content
  • Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Current Oncology, Volume 17, Issue 3

2010 June - 13 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (13)

  • Article
  • Open Access
106 Citations
2,594 Views
11 Pages

1 June 2010

Background: Video-consultation (VC) is a specialized type of telemedicine that uses technology to provide real-time visual and audio patient assessment at a distance. In the present review, we set out to evaluate whether VC is feasible for the assess...

  • Article
  • Open Access
18 Citations
1,282 Views
9 Pages

Multimodality Breast Cancer Screening in Women with a Familial or Genetic Predisposition

  • I. Trop,
  • L. Lalonde,
  • M.H. Mayrand,
  • J. David and ,
  • N. Larouche and
  • D. Provencher
  • + 1 author+ 0 author

1 June 2010

Background: Women with a predisposition for breast cancer require a tailored screening program for early cancer detection. We evaluated the performance of mammography (MG), ultrasonography (US), and magnetic resonance imaging (MRI) screening in these...

  • Article
  • Open Access
56 Citations
1,947 Views
12 Pages

Epidermal Growth Factor Receptor Targeted Therapy in Stages III and IV Head and Neck Cancer

  • C. Cripps,
  • E. Winquist,
  • M.C. Devries,
  • D. Stys–Norman and ,
  • R. Gilbert and
  • the Head and Neck Cancer Disease Site Group
  • + 1 author+ 0 author

1 June 2010

Question: What are the benefits associated with the use of anti–epidermal growth factor receptor (anti-EGFR) therapies in squamous cell carcinoma of the head and neck (HNSCC)? Anti-EGFR therapies of interest included cetuximab, gefitinib, lapatinib,...

  • Article
  • Open Access
37 Citations
3,600 Views
16 Pages

Consensus Recommendations for the Diagnosis and Management of Well-Differentiated Gastroenterohepatic Neuroendocrine Tumours: A Revised Statement from a Canadian National Expert Group

  • W. Kocha,
  • J. Maroun,
  • H. Kennecke,
  • C. Law and ,
  • P. Metrakos,
  • J.F. Ouellet,
  • R. Reid,
  • C. Rowsell,
  • A. Shah and
  • R. Wong
  • + 7 authors+ 2 authors

1 June 2010

Well-differentiated neuroendocrine tumours (NETS—previously called “carcinoid tumours”) are relatively rare tumours originating from the diffuse neuroendocrine system; they are found most often in the bronchial or gastrointestinal systems. In Canada,...

  • Article
  • Open Access
74 Citations
2,994 Views
5 Pages

Follow-Up for Women after Treatment for Cervical Cancer

  • L. Elit,
  • A.W. Fyles,
  • T.K. Oliver,
  • M.C. Devries–Aboud and ,
  • M. Fung-Kee-Fung and
  • members of the Gynecology Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care
  • + 1 author+ 0 author

1 June 2010

Question: What is the most appropriate follow-up strategy for patients with cervical cancer who are clinically disease-free after receiving primary treatment? Perspectives: For women with cervical cancer who have been treated with curative intent, fo...

  • Meeting Report
  • Open Access
9 Citations
1,119 Views
8 Pages

Eastern Canadian Colorectal Cancer Consensus Conference: Setting the Limits of Resectable Disease

  • M. Vickers,
  • B. Samson,
  • B. Colwell,
  • C. Cripps and ,
  • D. Jalink,
  • S. El-Sayed,
  • E. Chen,
  • G. Porter,
  • R. Goel and
  • T. Asmis
  • + 26 authors+ 21 authors

1 June 2010

The annual Eastern Canadian Colorectal Cancer Consensus Conference was held in Montreal, Quebec, October 22–24, 2009. Health care professionals involved in the care of patients with colorectal cancer participated in presentation and discussion sessio...

  • Article
  • Open Access
4 Citations
1,289 Views
5 Pages

Peritoneal Seeding and Subsequent Progression of Mantle Cell Lymphoma after Splenectomy for Debulking

  • G. Bahat,
  • B. Saka,
  • M.N. Yenerel,
  • E. Yilmaz and ,
  • C. Tascioglu and
  • O. Dogan
  • + 1 author+ 0 author

1 June 2010

Background: Peritoneal seeding after abdominal surgery is a well known route of metastasis in intra-abdominal solid tumours. Direct mechanical contamination, local peritoneal trauma and subsequent inflammation, postoperative immunosuppression, and la...

  • Article
  • Open Access
4 Citations
1,178 Views
3 Pages

1 June 2010

Background: Xeroderma pigmentosum, an autosomal recessive disease that occurs with a frequency of 1:250,000, is caused by a genetic defect in nucleotide excision repair enzymes. Mutation of these enzymes leads to the development of multiple basal cel...

  • Article
  • Open Access
109 Citations
2,769 Views
8 Pages

1 June 2010

Pancreatic cancer is an aggressive, drug-resistant disease; its first-line chemotherapeutic, gemcitabine, is only marginally effective. Intracellular depletion of glutathione, a major free-radical scavenger, has been associated with growth arrest and...

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729